Granules India Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹96.99 billion
- Book Value:
- Revenue TTM:
- ₹28.98 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹12.50 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Granules India Limited had its IPO on under the ticker symbol 532482.
The company operates in the Healthcare sector and Drug Manufacturers - Major industry. Granules India Limited has a staff strength of 3,029 employees.
Shares of Granules India Limited opened at ₹316.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹306.05 - ₹318, and closed at ₹307.7.
This is a -2.01% slip from the previous day's closing price.
A total volume of 179,896 shares were traded at the close of the day’s session.
In the last one week, shares of Granules India Limited have increased by +0.75%.
Granules India Limited's Key Ratios
Granules India Limited has a market cap of ₹96.99 billion, indicating a price to book ratio of 4.8877 and a price to sales ratio of 3.2998.
In the last 12-months Granules India Limited’s revenue was ₹28.98 billion with a gross profit of ₹12.50 billion and an EBITDA of ₹7.33 billion. The EBITDA ratio measures Granules India Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Granules India Limited’s operating margin was 20.36% while its return on assets stood at 11.07% with a return of equity of 23.91%.
In Q3, Granules India Limited’s quarterly earnings growth was a positive 74.5% while revenue growth was a positive 22.7%.
Granules India Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹17 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Granules India Limited’s profitability.
Granules India Limited stock is trading at a EV to sales ratio of 3.3968 and a EV to EBITDA ratio of 12.9444. Its price to sales ratio in the trailing 12-months stood at 3.2998.
Granules India Limited stock pays annual dividends of ₹1 per share, indicating a yield of 0.27% and a payout ratio of 2.93%.
Balance sheet and cash flow metrics
- Total Assets
- ₹49.05 billion
- Total Liabilities
- ₹18.14 billion
- Operating Cash Flow
- Capital Expenditure
- ₹4.11 billion
- Dividend Payout Ratio
Granules India Limited ended 2023 with ₹49.05 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹49.05 billion while shareholder equity stood at ₹28.35 billion.
Granules India Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹18.14 billion in other current liabilities, 242040000.00 in common stock, ₹28.11 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹3.16 billion. The company’s total short-term debt was ₹8,108,820,000 while long-term debt stood at ₹1.49 billion.
Granules India Limited’s total current assets stands at ₹25.74 billion while long-term investments were ₹0 and short-term investments were ₹31.67 million. Its net receivables were ₹9.49 billion compared to accounts payable of ₹0 and inventory worth ₹11.49 billion.
In 2023, Granules India Limited's operating cash flow was ₹-1913630000.00 while its capital expenditure stood at ₹4.11 billion.
Comparatively, Granules India Limited paid ₹0.03 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Granules India Limited stock is currently trading at ₹307.7 per share. It touched a 52-week high of ₹379.4482 and a 52-week low of ₹379.4482. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹306.67 and 200-day moving average was ₹301.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4684% of the company’s stock are held by insiders while 1927.8% are held by institutions.
Frequently Asked Questions About Granules India Limited
Similar Industry Stocks (Drug Manufacturers - Major)
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. The company’s APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.